Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 102 holding rows worth $2,494,140,000.

Accession
0001053906-19-000010
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 109 entries on the cover page, a total value of $2,494,140,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,494,140,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WW INTL INC98262P101COM14,818,300$560,428,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK60,240,864$181,325,000thousands by filing date
Bristol-Myers Squibb Company110122108COM3,500,000$177,485,000thousands by filing datecall
AVANTOR INC COM05352A100Stock6,000,000$88,200,000thousands by filing date
Bank of America Corp060505104COM3,000,000$87,510,000thousands by filing datecall
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR650,000$79,599,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS450,000$75,254,000thousands by filing date
MODERNA INC60770K107COM4,606,298$73,332,000thousands by filing date
MEDICINES CO584688105COM1,400,000$70,000,000thousands by filing date
Morgan Stanley617446448COM1,500,000$64,005,000thousands by filing datecall
ACCELERON PHARMA INC00434H108COM1,500,000$59,265,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock700,000$56,294,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM600,000$44,082,000thousands by filing date
NVIDIA Corp67066G104COM200,000$34,814,000thousands by filing date
MORPHIC HLDG INC61775R105COM1,819,186$32,945,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM2,000,000$31,060,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock1,608,968$27,015,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR200,000$22,792,000thousands by filing date
RUBIUS THERAPEUTICS INC78116T103COM2,833,791$22,246,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,500,000$21,180,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM150,000$21,044,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM2,346,040$20,997,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,500,000$20,050,000thousands by filing date
ZILLOW GROUP INC CL C CAP STK98954M200Stock650,000$19,383,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH250,000$19,063,000thousands by filing datecall
INCYTE CORP COM45337C102Stock250,000$18,558,000thousands by filing datecall
SOLID BIOSCIENCES INC COM NEW83422E105Stock1,700,000$17,578,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM350,000$16,982,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM500,000$16,970,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS100,000$16,723,000thousands by filing datecall
CYCLERION THERAPEUTICS INC23255M105COM1,361,584$16,502,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM200,000$15,582,000thousands by filing date
EPIZYME INC29428V104COM1,500,000$15,473,000thousands by filing date
Uber Technologies90353T100COM500,000$15,235,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM400,000$15,040,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR150,000$14,448,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM1,000,000$14,360,000thousands by filing date
AMERICAN AIRLINES GROUP INC COM02376R102Stock500,000$13,485,000thousands by filing datecall
AGIOS PHARMACEUTICALS INC00847X104COM400,000$12,960,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM700,000$12,740,000thousands by filing date
THE REALREAL INC88339P101COM565,000$12,633,000thousands by filing date
TRICIDA INC89610F101COM360,000$11,113,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM600,000$10,929,000thousands by filing datecall
STONECO LTDG85158106COM CL A300,000$10,434,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock400,000$10,424,000thousands by filing date
XENCOR INC98401F105COMMON STOCK300,000$10,119,000thousands by filing date
DELPHI TECHNOLOGIES PLCG2709G107SHS750,000$10,050,000thousands by filing datecall
FIDELITY NATL INFORMATION SVCS COM31620M106Stock75,000$9,957,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock350,000$9,832,000thousands by filing date
Accelerate Diagnostics00430H102COM500,000$9,285,000thousands by filing date
BLUEBIRD BIO INC09609G100COM100,000$9,182,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM500,000$9,108,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK450,200$9,004,000thousands by filing date
MERUS N VN5749R100COM500,000$8,910,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM1,134,616$8,510,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK600,000$8,340,000thousands by filing date
MODERNA INC60770K107COM500,000$7,960,000thousands by filing datecall
MINERVA NEUROSCIENCES INC COM NEW603380106Stock1,000,000$7,750,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,300,000$7,488,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock750,000$7,433,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM471,846$7,092,000thousands by filing date
KALEIDO BIOSCIENCES INC483347100COM900,500$6,781,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM308,526$6,689,000thousands by filing date
FIBROGEN INC31572Q808COM180,000$6,656,000thousands by filing date
AGENUS INC00847G705COM NEW2,500,000$6,450,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM500,000$6,210,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock400,000$6,128,000thousands by filing date
ARQULE INC04269E107COM850,000$6,095,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM540,000$5,724,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock150,000$5,209,000thousands by filing date
REGENXBIO INC75901B107COM145,000$5,162,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock900,000$5,054,000thousands by filing date
AC IMMUNE SAH00263105SHS1,000,000$4,950,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock150,000$4,635,000thousands by filing date
LIONS GATE ENTMNT CORP535919401CL A VTG500,000$4,625,000thousands by filing datecall
RESTORBIO INC76133L103COM500,000$4,420,000thousands by filing date
BRIDGEBIO PHARMA INC10806X102COM200,000$4,294,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR350,000$4,158,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM500,000$4,010,000thousands by filing datecall
KURA ONCOLOGY INC COM50127T109Stock250,000$3,793,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM360,000$3,748,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM2,100,000$3,675,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM405,000$3,665,000thousands by filing date
IGM BIOSCIENCES INC449585108COM200,000$3,550,000thousands by filing date
DOUYU INTL HLDGS LTD25985W105SPONSORED ADS400,000$3,276,000thousands by filing date
ALECTOR INC014442107COMMON STOCK225,000$3,245,000thousands by filing date
111 INC68247Q102ADR650,000$3,166,000thousands by filing date
NIO INC SPON ADS62914V106ADR2,000,000$3,120,000thousands by filing date
Aravive Inc03890D108Common / Ordinary Stock400,000$3,000,000thousands by filing date
NIO INC SPON ADS62914V106ADR1,750,000$2,730,000thousands by filing datecall
ALLOGENE THERAPEUTICS INC019770106COM100,000$2,726,000thousands by filing date
AXCELLA HEALTH INC05454B105COM450,000$2,547,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM350,000$2,408,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM100,000$2,388,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM300,000$2,307,000thousands by filing date
GRITSTONE BIO INC39868T105COM250,000$2,159,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM500,000$1,965,000thousands by filing date
BLOCK INC CL A852234103Stock30,000$1,859,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK425,000$1,666,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock1,000,000$1,060,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK110,532$949,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock23,449$331,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-19-000010this filing2019-11-14acceptance time not in the bulk data set